home / lobbying / lobbying_activities

lobbying_activities: 512955

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
512955 61cc3ddf-2007-46b0-bfc6-8ce45972f078 MM PODESTA GROUP, INC. 31680 MATTOON & ASSOCIATES LLC 2007 mid_year PHA S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2007-08-07T07:51:41-04:00
Powered by Datasette · Queries took 0.381ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API